Last reviewed · How we verify
PBK-1801
At a glance
| Generic name | PBK-1801 |
|---|---|
| Sponsor | Pharmbio Korea Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PBK-1801 CI brief — competitive landscape report
- PBK-1801 updates RSS · CI watch RSS
- Pharmbio Korea Co., Ltd. portfolio CI